 | |
| Company type | Public limited company |
|---|---|
| ISIN | GB00BMX86B70 |
| Industry | |
| Predecessors | |
| Founded | 18 July 2022 |
| Headquarters | Weybridge, England, UK |
Area served | Worldwide |
Key people |
|
| Products |
|
| Brands | |
| Revenue |  £11,302 million (2023)
[1] |
| £1,996 million (2023)
[1] | |
 £1,111 million (2023)
[1] | |
| Total assets | £34,055 million (2023)
[1] |
| Total equity | £16,729 million (2023)
[1] |
Number of employees | 24,000 (2023) [2] |
| Website |
www |
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. [3] It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers and Centrum vitamins. [4] The company is a global leader in over the counter medicines with a 7.3 percent market share. [5]
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. [6]
Sir David Lewis is chairman, with Brian McNamara as CEO. [7] Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Annual sales amounted to around £10 billion across 120 markets in 2020. [5]
History
GSK and Pfizer merged their consumer healthcare businesses in 2019. [8] [9] GSK owned just over two thirds of the joint venture, and Pfizer held the remainder. [8]
GSK announced plans to spin-off Haleon in 2018, in order to give the "tired drugmaker extra focus and firepower by gearing up and hiving off the consumer division". [10]
Unilever offered £50 billion for the business in 2022, in a bid which GSK rejected. [11] Nestlé examined the possibility of a bid in conjunction with Reckitt. [12]
In October 2023, GSK reduced its ownership share in Haleon to just over 7.4%, [13] and again in January 2024 down to 4.2%. [14]
The Lamisil antifungal brand was sold to Karo Healthcare AB for £235 million in August 2023; the transaction was completed on November 2023. [15] [16]
The ChapStick lip care brand was sold to Yellow Wood Partners for £401 million in 2024. [17]
In March 2024, Pfizer reduced its stake in Haleon from 32% to 24% by selling 630 million shares in a public offering. [18]
In April 2024 Haleon announced that it planned to close its British factory in Maidenhead. [19] Toothpaste manufacturing would be relocated to Slovakia, with mouthwash production outsourced to a third-party. [20]
In June 2024, the company announced the sale of its non-US nicotine brands to Dr. Reddy's Laboratories in a deal worth £500 million. [21] [22]
Operations
Oral health accounted for 28.5 percent of revenue in 2021. [23]
Brands
Current
Brands include: [24]
- Abreva (Docosanol)
- Advil ( Ibuprofen)
- alli (Orlistat)
- Anadin (pain relief)
- Aquafresh (oral healthcare)
- Astring-o-Sol (oral healthcare)
- Be-Total (leader in vitamins market in Italy)
- Beechams Cold & Flu and Night/Day Nurse (cold and flu treatments)
- Biotene (oral healthcare)
- Boost (nutritional)
- Breathe Right (respiratory)
- Centrum (vitamins and naturals)
- Cetebe (vitamins and naturals)
- Chlorhexamed (oral healthcare)
- Cholinex (analgesics and respiratory tract)
- Citrucel (gastrointestinal)
- Coldrex (cold and flu treatment)
- Commit Lozenge (smoking cessation)
- Committed Quitters (nicotine replacement)
- Corega (oral healthcare)
- Corsodyl (oral healthcare)
- Crocin (analgesics and respiratory tract)
- Dr. Best (oral healthcare)
- Emergen-C
- ENO (gastrointestinal)
- Eumovate (dermatological)
- Excedrin
- Fenistil
- Fenbid (analgesics and respiratory tract)
- Flonase (fluticasone propionate)
- Foodles (noodles), origin: India
- Formigran (analgesic/triptan)
- Grand-PA (headache/toothache/pain and fever)
- Hinds (dermatological)
- Junior Horlicks (nutritional)
- Imedeen
- Iodex (pain relief)
- Iodosan (cold and flu treatment)
- Macleans (oral healthcare)
- Maltova (nutritional)
- Maxinutrition (nutritional)
- Med-Lemon (hot, cold and flu medication)
- Medacalm (vitamins and naturals)
- Nexium Control ( esomeprazole)
- Nicorette (nicotine replacement)
- Nicotinell
- Night Nurse (cold and flu remedy)
- NiQuitin CQ/ Nicoderm CQ/ Nicabate (nicotine replacement)
- Odol (oral healthcare)
- Odol-med3 (oral healthcare)
- Os-cal (oral healthcare)
- Otrivin/Otrivine ( xylometazoline)
- Panadeine (analgesics and respiratory tract)
- Panadol/Panodil (analgesics and respiratory tract)
- parodontax (oral healthcare)
- Piriton/Piriteze/Pirinase (anti-allergy)
- Polident (oral healthcare)
- Poligrip Ultra (oral healthcare)
- Robitussin (respiratory)
- Rutinoscorbin (vitamins and naturals)
- Scott's Emulsion (vitamins and naturals)
- Sensodyne (oral healthcare)
- Shumitect (oral healthcare)
- Solpadeine (analgesics and respiratory tract)
- Super Poligrip (oral healthcare)
- Super Wernet's (oral healthcare)
- Synthol (oral healthcare)
- Theraflu (Respiratory)
- Tums (gastrointestinal)
- Viva (vitamins and naturals), origin: Nepal
- Voltaren/Voltarol (anti inflammatory)
- Zovirax (dermatological)
Divested
- Lamisil ( terbinafine) (sold to Karo Healthcare in 2023)
- ChapStick (sold to Yellow Wood Partners in 2024)
References
- ^ a b c d e "Annual results 2023" (PDF). Haleon. Retrieved 29 February 2024.
- ^ "Haleon plots massive layoffs in UK and beyond to save costs: report". Fierce Pharma. 13 July 2023. Retrieved 11 February 2024.
- ^ "GSK announces independent Consumer Healthcare company is to be called Haleon | GSK". www.gsk.com. 22 February 2022. Retrieved 2023-02-21.
- ^ Ralph, Alex (2 July 2022). "GlaxoSmithKline prepares to get back to basics with historic break-up". The Times. Retrieved 4 July 2022.
- ^ a b Cornell, Joe (15 July 2021). "GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022". Forbes. Retrieved 10 June 2022.
- ^ "Prospectus" (PDF). GSK plc. p. 15. Archived from the original (PDF) on 1 June 2022. Retrieved 10 June 2022.
- ^ Kleinman, Mark (3 May 2022). "GSK's £45bn Panadol and Sensodyne-maker Haleon in talks to hire banks". Sky News. Retrieved 10 June 2022.
- ^ a b Shane, Daniel (19 December 2018). "Advil meet Excedrin: Pfizer and GSK are merging their consumer healthcare businesses". CNN. Retrieved 10 June 2022.
- ^ "Haleon Won't Indemnify Pfizer, GSK Over Zantac. Shares Are Up". Barron's. 20 September 2022. Retrieved 17 December 2022.
- ^ Donnellan, Aimee (9 June 2022). "GSK castoff starts life with target on its back". Reuters. Retrieved 10 June 2022.
- ^ Jolly, Jasper (19 January 2022). "Unilever will not increase £50bn offer for GSK consumer arm". The Guardian. Retrieved 10 June 2022.
- ^ "Nestle Eyed Biggest-Ever Deal in Aborted Move for GSK Unit". Bloomberg News. 25 May 2022. Retrieved 10 June 2022.
- ^ "GSK raises $1.1 billion from Haleon stake sale". Reuters. 2023-10-06. Retrieved 2023-10-09.
- ^ "GSK raises $1.24 bln from latest Haleon stake sale". Reuters. 2024-01-17. Retrieved 2024-01-18.
- ^ Healthcare, Karo (2 August 2023). "Karo Healthcare acquires the Global OTC brand Lamisil® from Haleon". Karo Healthcare. Retrieved 5 June 2024.
- ^ Healthcare, Karo (1 November 2023). "Karo Healthcare completes the acquisition of the rights to the Global OTC brand Lamisil® from Haleon". Karo Healthcare. Retrieved 5 June 2024.
- ^ Williams, Holly (25 January 2024). "Haleon offloads ChapStick lip balm brand in £401m deal". The Standard. Retrieved 20 February 2024.
- ^ "Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24%". Yahoo Finance. 2024-03-18. Retrieved 2024-03-19.
- ^ Briant, Nathan (30 April 2024). "Sensodyne maker set to cut 435 jobs". BBC News. Retrieved 8 May 2024.
- ^ Mathews, Eva (30 April 2024). "Sensodyne-maker Haleon to shut UK plant, 435 jobs to go". Reuters. Retrieved 8 May 2024.
- ^ Ralph, Alex (2024-06-27). "Haleon quits nicotine replacement with £500m sale of brands". www.thetimes.com. Retrieved 2024-06-27.
- ^ "London Stock Exchange | London Stock Exchange". www.londonstockexchange.com. Retrieved 2024-06-27.
- ^ "Update: Proposed demerger of the Consumer Healthcare business from GSK to form Haleon". GSK. 6 January 2022. Retrieved 10 June 2022.
- ^ "Our Consumer Healthcare Brands". Haleon. Retrieved 19 July 2022.
External links
- Official website
- Business data for Haleon:
| Brands | |
|---|---|
| People |
|
| Related | |
| Subsidiaries |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Predecessors, acquisitions | |||||||||
| Products |
| ||||||||
| People |
| ||||||||
| Litigation | |||||||||
| Other | |||||||||
- Haleon
- 2022 establishments in England
- Companies based in Surrey
- Companies listed on the London Stock Exchange
- Corporate spin-offs
- Dental companies
- Health care companies of England
- Manufacturing companies of England
- Manufacturing companies established in 2022
- Multinational companies headquartered in England
- Personal care companies
- Weybridge, Surrey
- Companies in the FTSE 100 Index
|
| |
| Company type | Public limited company |
|---|---|
| ISIN | GB00BMX86B70 |
| Industry | |
| Predecessors | |
| Founded | 18 July 2022 |
| Headquarters | Weybridge, England, UK |
Area served | Worldwide |
Key people |
|
| Products |
|
| Brands | |
| Revenue | £11,302 million (2023)
[1] |
| £1,996 million (2023)
[1] | |
| £1,111 million (2023)
[1] | |
| Total assets | £34,055 million (2023)
[1] |
| Total equity | £16,729 million (2023)
[1] |
Number of employees | 24,000 (2023) [2] |
| Website |
www |
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. [3] It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers and Centrum vitamins. [4] The company is a global leader in over the counter medicines with a 7.3 percent market share. [5]
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. [6]
Sir David Lewis is chairman, with Brian McNamara as CEO. [7] Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Annual sales amounted to around £10 billion across 120 markets in 2020. [5]
History
GSK and Pfizer merged their consumer healthcare businesses in 2019. [8] [9] GSK owned just over two thirds of the joint venture, and Pfizer held the remainder. [8]
GSK announced plans to spin-off Haleon in 2018, in order to give the "tired drugmaker extra focus and firepower by gearing up and hiving off the consumer division". [10]
Unilever offered £50 billion for the business in 2022, in a bid which GSK rejected. [11] Nestlé examined the possibility of a bid in conjunction with Reckitt. [12]
In October 2023, GSK reduced its ownership share in Haleon to just over 7.4%, [13] and again in January 2024 down to 4.2%. [14]
The Lamisil antifungal brand was sold to Karo Healthcare AB for £235 million in August 2023; the transaction was completed on November 2023. [15] [16]
The ChapStick lip care brand was sold to Yellow Wood Partners for £401 million in 2024. [17]
In March 2024, Pfizer reduced its stake in Haleon from 32% to 24% by selling 630 million shares in a public offering. [18]
In April 2024 Haleon announced that it planned to close its British factory in Maidenhead. [19] Toothpaste manufacturing would be relocated to Slovakia, with mouthwash production outsourced to a third-party. [20]
In June 2024, the company announced the sale of its non-US nicotine brands to Dr. Reddy's Laboratories in a deal worth £500 million. [21] [22]
Operations
Oral health accounted for 28.5 percent of revenue in 2021. [23]
Brands
Current
Brands include: [24]
- Abreva (Docosanol)
- Advil ( Ibuprofen)
- alli (Orlistat)
- Anadin (pain relief)
- Aquafresh (oral healthcare)
- Astring-o-Sol (oral healthcare)
- Be-Total (leader in vitamins market in Italy)
- Beechams Cold & Flu and Night/Day Nurse (cold and flu treatments)
- Biotene (oral healthcare)
- Boost (nutritional)
- Breathe Right (respiratory)
- Centrum (vitamins and naturals)
- Cetebe (vitamins and naturals)
- Chlorhexamed (oral healthcare)
- Cholinex (analgesics and respiratory tract)
- Citrucel (gastrointestinal)
- Coldrex (cold and flu treatment)
- Commit Lozenge (smoking cessation)
- Committed Quitters (nicotine replacement)
- Corega (oral healthcare)
- Corsodyl (oral healthcare)
- Crocin (analgesics and respiratory tract)
- Dr. Best (oral healthcare)
- Emergen-C
- ENO (gastrointestinal)
- Eumovate (dermatological)
- Excedrin
- Fenistil
- Fenbid (analgesics and respiratory tract)
- Flonase (fluticasone propionate)
- Foodles (noodles), origin: India
- Formigran (analgesic/triptan)
- Grand-PA (headache/toothache/pain and fever)
- Hinds (dermatological)
- Junior Horlicks (nutritional)
- Imedeen
- Iodex (pain relief)
- Iodosan (cold and flu treatment)
- Macleans (oral healthcare)
- Maltova (nutritional)
- Maxinutrition (nutritional)
- Med-Lemon (hot, cold and flu medication)
- Medacalm (vitamins and naturals)
- Nexium Control ( esomeprazole)
- Nicorette (nicotine replacement)
- Nicotinell
- Night Nurse (cold and flu remedy)
- NiQuitin CQ/ Nicoderm CQ/ Nicabate (nicotine replacement)
- Odol (oral healthcare)
- Odol-med3 (oral healthcare)
- Os-cal (oral healthcare)
- Otrivin/Otrivine ( xylometazoline)
- Panadeine (analgesics and respiratory tract)
- Panadol/Panodil (analgesics and respiratory tract)
- parodontax (oral healthcare)
- Piriton/Piriteze/Pirinase (anti-allergy)
- Polident (oral healthcare)
- Poligrip Ultra (oral healthcare)
- Robitussin (respiratory)
- Rutinoscorbin (vitamins and naturals)
- Scott's Emulsion (vitamins and naturals)
- Sensodyne (oral healthcare)
- Shumitect (oral healthcare)
- Solpadeine (analgesics and respiratory tract)
- Super Poligrip (oral healthcare)
- Super Wernet's (oral healthcare)
- Synthol (oral healthcare)
- Theraflu (Respiratory)
- Tums (gastrointestinal)
- Viva (vitamins and naturals), origin: Nepal
- Voltaren/Voltarol (anti inflammatory)
- Zovirax (dermatological)
Divested
- Lamisil ( terbinafine) (sold to Karo Healthcare in 2023)
- ChapStick (sold to Yellow Wood Partners in 2024)
References
- ^ a b c d e "Annual results 2023" (PDF). Haleon. Retrieved 29 February 2024.
- ^ "Haleon plots massive layoffs in UK and beyond to save costs: report". Fierce Pharma. 13 July 2023. Retrieved 11 February 2024.
- ^ "GSK announces independent Consumer Healthcare company is to be called Haleon | GSK". www.gsk.com. 22 February 2022. Retrieved 2023-02-21.
- ^ Ralph, Alex (2 July 2022). "GlaxoSmithKline prepares to get back to basics with historic break-up". The Times. Retrieved 4 July 2022.
- ^ a b Cornell, Joe (15 July 2021). "GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022". Forbes. Retrieved 10 June 2022.
- ^ "Prospectus" (PDF). GSK plc. p. 15. Archived from the original (PDF) on 1 June 2022. Retrieved 10 June 2022.
- ^ Kleinman, Mark (3 May 2022). "GSK's £45bn Panadol and Sensodyne-maker Haleon in talks to hire banks". Sky News. Retrieved 10 June 2022.
- ^ a b Shane, Daniel (19 December 2018). "Advil meet Excedrin: Pfizer and GSK are merging their consumer healthcare businesses". CNN. Retrieved 10 June 2022.
- ^ "Haleon Won't Indemnify Pfizer, GSK Over Zantac. Shares Are Up". Barron's. 20 September 2022. Retrieved 17 December 2022.
- ^ Donnellan, Aimee (9 June 2022). "GSK castoff starts life with target on its back". Reuters. Retrieved 10 June 2022.
- ^ Jolly, Jasper (19 January 2022). "Unilever will not increase £50bn offer for GSK consumer arm". The Guardian. Retrieved 10 June 2022.
- ^ "Nestle Eyed Biggest-Ever Deal in Aborted Move for GSK Unit". Bloomberg News. 25 May 2022. Retrieved 10 June 2022.
- ^ "GSK raises $1.1 billion from Haleon stake sale". Reuters. 2023-10-06. Retrieved 2023-10-09.
- ^ "GSK raises $1.24 bln from latest Haleon stake sale". Reuters. 2024-01-17. Retrieved 2024-01-18.
- ^ Healthcare, Karo (2 August 2023). "Karo Healthcare acquires the Global OTC brand Lamisil® from Haleon". Karo Healthcare. Retrieved 5 June 2024.
- ^ Healthcare, Karo (1 November 2023). "Karo Healthcare completes the acquisition of the rights to the Global OTC brand Lamisil® from Haleon". Karo Healthcare. Retrieved 5 June 2024.
- ^ Williams, Holly (25 January 2024). "Haleon offloads ChapStick lip balm brand in £401m deal". The Standard. Retrieved 20 February 2024.
- ^ "Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24%". Yahoo Finance. 2024-03-18. Retrieved 2024-03-19.
- ^ Briant, Nathan (30 April 2024). "Sensodyne maker set to cut 435 jobs". BBC News. Retrieved 8 May 2024.
- ^ Mathews, Eva (30 April 2024). "Sensodyne-maker Haleon to shut UK plant, 435 jobs to go". Reuters. Retrieved 8 May 2024.
- ^ Ralph, Alex (2024-06-27). "Haleon quits nicotine replacement with £500m sale of brands". www.thetimes.com. Retrieved 2024-06-27.
- ^ "London Stock Exchange | London Stock Exchange". www.londonstockexchange.com. Retrieved 2024-06-27.
- ^ "Update: Proposed demerger of the Consumer Healthcare business from GSK to form Haleon". GSK. 6 January 2022. Retrieved 10 June 2022.
- ^ "Our Consumer Healthcare Brands". Haleon. Retrieved 19 July 2022.
External links
- Official website
- Business data for Haleon:
| Brands | |
|---|---|
| People |
|
| Related | |
| Subsidiaries |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Predecessors, acquisitions | |||||||||
| Products |
| ||||||||
| People |
| ||||||||
| Litigation | |||||||||
| Other | |||||||||
- Haleon
- 2022 establishments in England
- Companies based in Surrey
- Companies listed on the London Stock Exchange
- Corporate spin-offs
- Dental companies
- Health care companies of England
- Manufacturing companies of England
- Manufacturing companies established in 2022
- Multinational companies headquartered in England
- Personal care companies
- Weybridge, Surrey
- Companies in the FTSE 100 Index